Journal
Open Forum Infectious Diseases
Publication Date
8-1-2023
Volume
10
Issue
8
First Page
ofad419
Document Type
Open Access Publication
DOI
10.1093/ofid/ofad419
Rights and Permissions
Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, David R Boulware, Todd C Lee, Rachel Hess, Alexander J Lankowski, Emily G McDonald, J Philip Miller, William G Powderly, Matthew F Pullen, Jeffrey T Rado, Michael W Rich, Joshua T Schiffer, Julie Schweiger, Adam M Spivak, Angela Stevens, Simone N Vigod, Payal Agarwal, Lei Yang, Michael Yingling, Torie R Gettinger, Charles F Zorumski, Eric J Lenze, The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial, Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad419, https://doi.org/10.1093/ofid/ofad419. https://academic.oup.com/ofid/article/10/8/ofad419/7238414?login=true. © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Reiersen, Angela M; Mattar, Caline; Miller, J Philip; Powderly, William G; Rich, Michael W; Schweiger, Julie; Stevens, Angela; Yang, Lei; Yingling, Michael; Gettinger, Torie R; Zorumski, Charles F; Lenze, Eric J; and et al., "The STOP COVID 2 study: Fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully remote randomized controlled trial." Open Forum Infectious Diseases. 10, 8. ofad419 (2023).
https://digitalcommons.wustl.edu/oa_4/2253
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
